| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by investing activities | 67,342 | -26,274 |
| Issuance of common stock pursuant to exercise of stock options | 0 | 0 |
| Return of related party short swing profits | 215 | 215 |
| Repurchase of restricted stock units to satisfy tax withholding | 67 | - |
| Net cash provided by financing activities | 148 | 215 |
| Net change in cash, cash equivalents and restricted cash | -87,684 | -130,813 |
| Cash and cash equivalents at beginning of period | 164,997 | - |
| Cash and cash equivalents at end of period | 77,313 | - |
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)